PPP1R12A

Chr 12AD

protein phosphatase 1 regulatory subunit 12A

Also known as: GUBS, M130, MBS, MYPT1

Myosin phosphatase target subunit 1, which is also called the myosin-binding subunit of myosin phosphatase, is one of the subunits of myosin phosphatase. Myosin phosphatase regulates the interaction of actin and myosin downstream of the guanosine triphosphatase Rho. The small guanosine triphosphatase Rho is implicated in myosin light chain (MLC) phosphorylation, which results in contraction of smooth muscle and interaction of actin and myosin in nonmuscle cells. The guanosine triphosphate (GTP)-bound, active form of RhoA (GTP.RhoA) specifically interacted with the myosin-binding subunit (MBS) of myosin phosphatase, which regulates the extent of phosphorylation of MLC. Rho-associated kinase (Rho-kinase), which is activated by GTP. RhoA, phosphorylated MBS and consequently inactivated myosin phosphatase. Overexpression of RhoA or activated RhoA in NIH 3T3 cells increased phosphorylation of MBS and MLC. Thus, Rho appears to inhibit myosin phosphatase through the action of Rho-kinase. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2009]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismADLOEUF 0.131 OMIM phenotype
Clinical SummaryPPP1R12A
🧬
Gene-Disease Validity (ClinGen)
genitourinary and/or brain malformation syndrome · ADStrong

Strong evidence — appropriate for clinical testing

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
36 unique Pathogenic / Likely Pathogenic· 153 VUS of 307 total submissions
📖
GeneReview available — PPP1R12A
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.13LOEUF
pLI 1.000
Z-score 6.81
OE 0.05 (0.020.13)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint?
2.64Z-score
OE missense 0.67 (0.610.73)
342 obs / 509.5 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.05 (0.020.13)
00.351.4
Missense OE?0.67 (0.610.73)
00.61.4
Synonymous OE?0.98
01.21.6
LoF obs/exp: 3 / 59.8Missense obs/exp: 342 / 509.5Syn Z: 0.19
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongPPP1R12A-related holoprosencephaly spectrum and urogenital malformationsLOFAD

This gene — mechanism propensity

DN
0.3495th %ile
GOF
0.4085th %ile
LOF
0.82top 5%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 86% of P/LP variants are LoF · LOEUF 0.13

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

307 submitted variants in ClinVar

Classification Summary

Pathogenic15
Likely Pathogenic21
VUS153
Likely Benign57
Benign27
Conflicting17
15
Pathogenic
21
Likely Pathogenic
153
VUS
57
Likely Benign
27
Benign
17
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
14
0
1
0
15
Likely Pathogenic
17
4
0
0
21
VUS
3
138
7
5
153
Likely Benign
1
20
19
17
57
Benign
0
7
11
9
27
Conflicting
17
Total351693831290

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

14 pathogenic / likely-pathogenic (of 17) ClinVar copy-number / structural variants overlap PPP1R12A — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PPP1R12A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →